Strides Arcolab Ltd (STAR.NS)

STAR.NS on National Stock Exchange of India

1,244.45INR
3:52pm IST
Change (% chg)

Rs-30.10 (-2.36%)
Prev Close
Rs1,274.55
Open
Rs1,279.50
Day's High
Rs1,279.50
Day's Low
Rs1,238.00
Volume
540,512
Avg. Vol
533,827
52-wk High
Rs1,337.00
52-wk Low
Rs542.65

STAR.NS

Chart for STAR.NS

About

Strides Arcolab Limited (Strides) is an India-based global pharmaceutical company. The Company develops and manufactures a range of intellectual property (IP)-led pharmaceutical products. The Company’s business division includes Pharma Generics, Branded Generics, Institutional Business and Bio-Generics. The Company’s Pharma... (more)

Overall

Beta: 0.75
Market Cap(Mil.): Rs75,995.84
Shares Outstanding(Mil.): 59.63
Dividend: 3.00
Yield (%): 0.24

Financials

  STAR.NS Industry Sector
P/E (TTM): 10.49 37.25 40.68
EPS (TTM): 121.47 -- --
ROI: 26.16 16.52 15.78
ROE: 41.93 17.30 16.82
Search Stocks

BUZZ-India's Strides, Shasun slump; govt body rejects merger application

** Strides Arcolab Ltd falls as much as 5 pct, Shasun Pharmaceuticals Ltd slumps as much as 14.3 pct

18 Jun 2015

Strides to buy Australia, Mauritius drug assets from Aspen for $300 million

MUMBAI - Indian drugmaker Strides Arcolab Ltd has agreed to buy businesses in Australia and Mauritius from South Africa's Aspen Pharmacare Holdings Ltd , paying $300 million to expand its footprint in markets set for brisk growth.

21 May 2015

UPDATE 1-India's Strides to buy Australia, Mauritius drug assets from Aspen for $300 mln

MUMBAI, May 21 - Indian drugmaker Strides Arcolab Ltd has agreed to buy businesses in Australia and Mauritius from South Africa's Aspen Pharmacare Holdings Ltd , paying $300 million to expand its footprint in markets set for brisk growth.

21 May 2015

India's Strides Arcolab to buy some Australia drug assets from Aspen Pharmacare

MUMBAI, May 21 - Indian drugmaker Strides Arcolab Ltd said on Thursday it has agreed to buy a generic drugs business in Australia from South Africa's Aspen Pharmacare Holdings Ltd for about A$380 million ($299.90 million).

21 May 2015

BUZZ-India's Strides Arcolab up on hopes key drug will gain U.S. market share

** Strides Arcolab Ltd gains 2.2 pct, Dr.Reddy's Laboratories Ltd up 2 pct

31 Mar 2015

BUZZ-India's Strides, Shasun rise; competition watchdog approves merger

** India's Strides Arcolab Ltd gains 4.8 pct and Shasun Pharmaceuticals Ltd rises 3.4 pct

24 Mar 2015

Earnings vs. Estimates

Search Stocks